Boundless Bio to Present at the 2023 Jefferies Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)-- Boundless Bio, a clinical stage, next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) for patients with oncogene amplified cancers, today announced that Chief Medical Officer, Klaus Wagner, M.D., Ph.D., will present at the 2023 Jefferies Healthcare Conference which will take place in New York City. Presentation details are as follows:

Date: Thursday, June 8, 2023
Time: 4:00 – 4:25 PM ET
Location: New York Marriott Marquis

About Boundless Bio

Boundless Bio is a clinical stage, next-generation precision oncology company dedicated to the discovery and development of new drugs targeting a novel area of cancer biology, ecDNA, to deliver transformative therapies intended to improve and extend the lives of patients with oncogene amplified cancers.

For more information, visit www.boundlessbio.com.

Follow us on LinkedIn and Twitter.

Contacts

James Lee, Boundless Bio
jlee@boundlessbio.com

Media
Dan Budwick, 1AB
dan@1abmedia.com

 
 

Source: Boundless Bio

Back to news